James V. Caruso, President and CEO at Cellectar Biosciences, Inc. (CLRB), sold 34,000 shares at $1.20 ($41K) on 2018-03-12, disclosed to the SEC on 2018-03-14.
Scheduled sale ($41k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CLRB | BUY | 2021-03-05 | $9K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $25K | — | Filing → |